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Baicalein is one of the major constituents of Scutellaria baicalensis, and some cancer cells could be 
inhibited by it according to some studies in recent years. Mice tumor models of U14 cervical cancer was 
established in our study, baicalein of high and low dose (40 and 20 mg/kg, respectively) were given 
orally to mice. The tumor inhibition rates and the thymus (spleen) weight index were studied, the cell 
morphologies of tumor, liver and kidney were examined after HE stained, the percentage of apoptotic 
cells was detected by flow cytometer and the positive expression rates of Bcl-2 and Bax protein in 
tumor tissues were examined by the standard immunehistochemical SP method. The results showed 
that baicalein could inhibit the tumor growth obviously with the tumor inhibition rate of 58.98%. 
Besides, the apoptosis of tumor could be induced by baicalein with the apoptotic percentage of 16.92 ± 
0.65%. Moreover, compared with the negative control group, the expression of Bcl-2 was reduced, while 
that of Bax was increased after the treatment of Baicalein. So, baicalein could inhibit the growth of U14 
cervical cancer cells, and it might induce apoptosis by downregulating the level of Bcl-2 protein and 
upregulating that of Bax. 
 





Baicalein (5, 6, 7-trihydroxyflavone, BAE, C15H10O5) is 
one of the principle flavonoids extracted from the dry root 
of Scutellaria baicalensis and the ratio of baicalein to the 
dry material is about 5.41% (Min, 2009). It is also one of 
the major bioactive constituents of S. baicalensis and has 
a distinct structure as depicted in Figure 1. It has been 
reported that baicalein has a variety of pharmacological 
effects, including anti-microbial, anti-viral, anti-
inflammatory, anti-oxidant, scavenging oxygen free 
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protection (Zhang et al., 2001) and so on. It has been 
discovered that baicalein can inhibit the proliferation of 
some cancer cells, such as breast cancer (Po et al., 
2002), ovarian cancer (Li et al., 2004), gastric cancer (Xie 
et al., 2006), liver cancer (Chen et al., 2009), esophageal 
cancer (Yao and Guo, 2010) and so forth. However, the 
inhibition effect and detailed mechanism of the treatment 
with baicalein on cervical cancer is not very clear up till 
now. 
In the present study, we investigated the anticancer 
effect of baicalein on the mice bearing U14 cervical 
cancer and attempted to elucidate the possible mecha-
nism behind it by detecting some indicators, so as to 
provide the scientific basis for the inhibition effect of 
baicalein on cervical cancer.   










MATERIALS AND METHODS 
 
Female Kun Ming mice of 6 weeks old (17 to 21 g) were provided 
by the Experimental Animal Center of Chinese Military Academy of 
Medical Sciences, with Lot Number SCXK-(Army) 2007-004. Mice 
were kept in plastic cages in a clean room with appropriate 
temperature (20±1°C) and humidity, and provided 8 to 10 h 
illumination every day. They were fed with a standard pellet diet and 
water ad libitum. The animals were treated according to the 
National Institute of Health Guide for the Care and Use of 
Laboratory Animals and their experimental use was approved by 
the Animal Ethics Committee of the University. 
 
 
Chemicals and reagents 
 
CTX (Cyclophosphamide) was purchased from Shanxi Powerdone 
Pharmaceutical Co., Ltd. in China, with Lot number 1008421, and 
diluted to the concentration of 25 mg/kg by physiological saline 
before use. Baicalein was provided by Nanjing ZeLang Medical 
Technology Co., Ltd. in China, and the determined purity was 98%. 
HE (Hematoxylin and Eosin) staining kit was obtained from 
Beyotime Institute of Biotechnology in China, annexin V-FITC 
apoptosis detection kit was obtained from Nanjing KeyGen Biotech. 
Co., Ltd. in China, immunohistochemical staining kit and 
concentrated DAB kit were purchased from Zhongshan 
Goldenbridge Biotechnology Co., Ltd. in China, while rabbit anti-
Bcl-2 and anti-Bax were purchased from Beijing biosynthesis 






Mouse U14 cervical cancer cell line was obtained from the Peking 
Cancer Hospital Cell Bank of Chinese Academy Medical Sciences, 
and placed in Kun Ming mice abdomen. 
 
 
Establishment of mice cervical cancer models 
 
The experimental mice were divided into 4 groups randomly 
consisting of 10 mice per group. The 4 groups were designated as 
tumor control group, CTX treated group, baicalein high dose 
(40mg/kg) and low dose (20mg/kg) treated groups. Under sterile 
condition, 0.2 ml U14 cells (5×106 cell/ml) were injected into the left 
axilla S.C. per mouse. The rate of successful inoculation was 100%. 
Effect of baicalein on U14 solid tumor growth  
 
After 24 h of tumor inoculation, baicalein was given orally at a dose 
of 40 and 20 mg/kg body weight, (0.2 ml/day) respectively 
according to pre-test and the dose of active screening. The group 
administered with vehicle alone (distilled water, 0.2 ml/day, p.o.) 
was taken as control, while the group treated with CTX (25 mg/kg, 
0.1 ml/day, i.p.) was considered as the standard reference drug. All 
groups were continuously treated for 14 days. The living conditions 
of mice were observed every day, and the changes of tumor volume 
and body weight were monitored. On day 15, all animals were killed 
and the transplanted tumors of treated and control mice were 
harvested and weighed. The tumor inhibition rate was calculated by 
the formula: (C - T) / C × 100%, where “T” and “C” mean average 
tumor weight of treated groups and control group respectively. 
 
 
Effect of baicalein on thymus and spleen weight index in mice 
bearing tumor 
 
By the end of the experiment on day 15, the thymus and spleen of 
executed mice of all groups were collected and weighed, then the 
thymus and spleen weight indexes were calculated by the follow 
formulas: 
 
Thymus weight index = the average thymus weight (mg) / the 
average body weight (g) 
 
Spleen weight index = the average spleen weight (mg) / the 
average body weight (g) 
 
 
Effect of baicalein on tumor, liver and kidney in mice bearing 
tumor 
 
The tumor, liver and kidney of treated and control mice were 
excised and fixed in 10% neutral formalin at 4°C, embedded in 
paraffin, and cut into 4 M sections for histology study. The sections 
were stained with HE staining method and then examined for cell 
morphology by light microscope. 
 
 
Effect of baicalein on apoptosis of tumor cells 
 
The tumor tissues of all groups were cut into pieces and made into 
single cell suspension by filtering through 200 mesh nylon net. The 
cell   concentration   was   adjusted   to  1×106  cells/ml  after  being  




Table 1. Effect of baicalein on solid tumor growth. 
 
Group Treatment (mg/kg) 
Body weight (g) Tumor weight 
(g) 
Inhibition rate 
(%) Beginning End 
Control Vehicle 20.68±1.32 26.08±2.73 2.56±0.14 — 
CTX 25 20.83±1.52 20.15±1.79 0.86±0.09a 68.00% 
High dose of baicalein 40 20.15±0.86 21.83±0.70 1.05±0.08a,b 58.98% 
Low dose of baicalein 20 20.10±1.52 23.82±1.65 1.39±0.13a,b 45.62% 
 




Table 2. Effect of baicalein on thymus and spleen weight index. 
 
Group Treatment (mg/kg) Thymus index (mg/g) Spleen index (mg/g) 
Control Vehicle 4.1134±0.1238a 21.7873±1.9241a 
CTX 25 0.6178±0.0014 5.2442±0.6507 
High dose of baicalein 40 3.2124±0.1778a,b 8.3562±0.4487a,b 
Low dose of baicalein 20 2.5012±0.0754a,b 12.0057±1.1681a,b 
 




centrifuged and washed 3 times. 
 The cells were overnight fixed with cold 70% ethanol, mixed with 
Annexin V-FITC, and then stained with PI (propidium iodide) 
solution consisting of RNase for 15 min. The percentage of 
apoptotic cells was detected by flow cytometer using multicycle AV 
and the excitation wavelength was 488 nm. The results were 
handled as follows: cells in lower left quadrant (Annexin V (-) / PI (-
)) were considered as living cells, cells in lower right quadrant 
(Annexin V (+) / PI (-)) were apoptotic cells, cells in upper right 
quadrant (Annexin V (+) / PI (+)) were necrotic or advanced 
apoptotic cells, while those in upper left quadrant (Annexin V (-) / PI 
(+)) were cellular debris. 
 
 
Effect of baicalein on expression of Bcl-2 and Bax protein in 
tumor tissues 
 
The harvested tumors of all groups were fixed in 10% formalin, 
embedded in paraffin and cut into 4 m sections. Tumor tissue 
sections were stained with the standard immunohistochemical SP 
(streptavidin peroxidase conjunction) method and stained with DAB, 
and then the sections were mounted with neutral gum and 
observed under light microscope. The number of Bcl-2 and Bax 
positive cells were counted with a hemacytometer under 400 × 





The data were expressed as mean ± S.D. The statistical analysis 
was performed by one-way analysis of variance, and differences 
between means were tested using Duncan’s multiple range tests. 
P-values of less than 0.05 were considered significant in statistics. 




Effect of baicalein on U14 solid tumor growth 
 
Compared with the tumor weight of the control group, the 
tumor weight of the CTX group and the baicalein groups 
were reduced respectively (P<0.05) and the tumor weight 
of the baicalein groups were bigger than that of the CTX 
group (P<0.05). However, there was no difference among 
the baicalein groups with each other (P>0.05). Both of the 
baicalein groups could inhibit the tumor growth 
significantly (P<0.05) and the tumor inhibition rates of the 
high and low dose baicalein groups were 58.98 and 
45.62% respectively (Table 1). The mice in the baicalein 
groups were all in good spirits. At the end of the experi-
ment, the mice in the CTX group lost their appetite, were 
in bad condition and the final body weight were 
decreased obviously. While the body weight of the other 3 
groups were increased compared with the beginning and 
the mice of the baicalein groups were in good situation, 
water and food they took in were similar to normal mice. 
Moreover, the mice of the baicalein groups were more 
sensitive to stimulation, and the color and smoothness of 
fur were better than those of the CTX group. 
 
 
Effect of baicalein on thymus and spleen weight 
index in mice bearing tumor 
 
As shown in Table 2, compared with the CTX group, the 
thymus and spleen indexes of the baicalein  groups  were  
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Figure 2. Tumor tissue sections of HE staining (10×40). (A) Tumor tissue section of control group, (B) Tumor 
tissue section of CTX group, (C) Tumor tissue section of high dose baicalein group, (D) Tumor tissue section of 
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Figure 3. Kidney and liver tissues sections of HE staining (10 × 40). (A) Kidney tissue sections of high 




increased dramatically. The thymus weight index of high 
dose of baicalein was increased to 3.2124 ± 0.1778 
mg/g, while the spleen weight index was increased to 
8.3562 ± 0.4487 mg/g. The thymus weight index of low 
dose of baicalein was 2.5012 ± 0.0754 mg/g, the spleen 
weight index was 12.0057 ± 1.1681 mg/g. Both the 
thymus weight and spleen weight indexes of the baicalein 
groups were increased significantly in contrast to the CTX 
group (P<0.05). The thymus index and spleen index of 
the baicalein groups were less than those of the control 
group (P<0.05), and there was no significant difference 
between the high and low dose of the baicalein group 
(P>0.05). 
Observation of cell morphology of tumor, liver and 
kidney 
 
The forms of tumor cells in all groups were observed after 
HE staining. The number of tumor cells in the CTX group 
and baicalein groups was reduced obviously compared 
with the tumor control group (Figure 2). The color and 
texture of liver and kidney were observed with naked 
eyes and there were no toxic effects on liver and kidney 
tissue. Then we conducted pathological examination of 
liver and kidney by HE staining. As shown in Figure 3, 
there were no obviously pathological changes in liver and 
kidney tissues of baicalein  groups,  the  color,  gloss  and  




Table 3. Effect of Baicalein on apoptosis of tumor cells. 
 
Group Treatment (mg/kg) Percentage of apoptosis cells (%) 
Control Vehicle 10.86±0.37 
CTX 25 27.52±0.32a 
High dose of baicalin 40 16.92±0.65a,b 
Low dose of baicalin 20 12.42±0.70a,b 
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Figure 4. Effect of baicalein on the expression of Bax protein (10 × 40). (A) Control group, (B) CTX 




texture were normal. The sections of liver and kidney 
showed that central vein and hepatic lobule were clear, 
glomerular and renal tubular were also evident. The data 
indicate that the administration of baicalein of both doses 
did not affect liver and kidney tissues. 
 
 
Effect of baicalein on apoptosis of tumor cells 
 
The percentage of apoptotic cells in the control group 
was 10.86 ± 0.37%. The percentage of apoptotic cells in 
the CTX group, the high and the low baicalein group were 
increased respectively (Table 3). There was a significant 
increase on the percentage of apoptotic cells in the 
baicalein groups compared with the control group 
(P<0.05). However, there was a significant reduction in 
the percentage of apoptotic cells of the baicalein groups 
compared to the CTX group (P<0.05), but there was no 
significant difference between the high and low dose of 
baicalein group (P>0.05). 
 
 
Effect of baicalein on expression of Bcl-2 and Bax 
protein in tumor tissues 
 
The percentage of Bax positive cells in the control group 
was 13.33 ± 0.62%, while the percentages of the 
baicalein groups and the CTX group were increased 
significantly (P<0.05) (Figure 4 and Table 4). The 
percentage of Bcl-2 positive cells in the control group was 
53.28 ± 0.46%, while the percentages of the baicalein 
groups were 42.83 ± 2.33 and 46.21 ± 1.64%, in high and




Table 4. Effect of baicalein on the expression of Bcl-2 and Bax protein. 
 
Group Treatment (mg/kg) Bcl-2 positive cells (%) Bax positive cells (%) Bax/Bcl-2 
Control Vehicle 53.28 ± 0.46 13.33 ± 0.62 0.25 
CTX 25 35.42 ± 0.82a 35.12 ± 0.93a 0.99 
High dose of baicalein 40 42.83 ± 2.33a,b 26.32 ± 1.41a,b 0.61 
Low dose of baicalein 20 46.21 ± 1.64a,b 20.63 ± 1.05a,b 0.45 
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Figure 5. Effect of baicalein on the expression of Bcl-2 protein (10 × 40). (A) Control group, (B) CTX 




low dose group respectively (Figure 5 and Table 4). 
Compared with the control group, both of the high dose 
and low dose of the baicalein groups could reduce the 
expression of Bcl-2 and increase the expression of Bax 
(P<0.05). Compared with the CTX group, the regulation 
effect on Bcl-2 and Bax in the baicalein groups was 
weaken, and the expression of Bcl-2 was significantly 
increased, while the expression of Bax got a significantly 
decrease (P<0.05).There was no obvious difference 
between the high and low dose of the baicalein groups on 
the expression of Bcl-2 and Bax (P>0.05).The rate of 
Bax/Bcl-2 in high dose of baicalein was 0.61, while the 
rate in the low dose baicalein was 0.45, the Bax/Bcl-2 
rates of the baicalein groups were both increased 
compared with the control group (P<0.05), and less than 





In recent years, flavonoids of S. baicalensis were studied 





effects of S. baicalensis. As the major constituent, 
baicalein attracted more concern. Baicalein could inhibit 
the growth of some cancer cells according to previous 
researches, and the possible mechanisms were: inducing 
apoptosis by regulating the related apoptosis protein and 
enhancing the activity of Caspase-3 (Li et al., 2004; Lee 
et al.,2008; Tong et al., 2009), inducing cell cycle arrest 
(Lee et al., 2005), declining the expression of VEGF, 
inhibiting the vessel from growing (Xie et al., 2006), 
inhibiting the invasion and migration of cancer cells 
(Wang et al., 2010a; Wang et al., 2010b) and so on. Tong 
et al. (2009) proposed that the possible mechanism of 
baicalein inducing Hela cells apoptosis may be related to 
induce cells apoptosis and enhancing the activity of 
Caspase-3. 
According to our research, we found that baicalein 
might remarkably inhibit the growth of U14 cervical 
cancer tissues with the inhibition rate of 58.98% in the 
high dose group and 45.62% in the low dose group. The 
number of tumor cells in the high dose and low does 
baicalein groups was reduced obviously, and the rates of 
apoptosis in the baicalein groups were also increased. 
These results indicated that baicalein could induce the 
apoptosis of U14 cervical cancer cells. Observation from 
the pathological examination of liver and kidney indicated 
that there were no apparent pathological changes in the 
baicalein groups, which showed that baicalein almost had 
no toxic effects to liver and kidney tissues in model mice. 
It is well known that there is a close link between the 
occurrence and development of tumor and the decreased 
immune function of body. The immune dysfunction often 
occurred in cancer patients, however, most of anti-cancer 
drugs have great impact on immune function when 
destroying tumor cells, and cause the abnormality of 
immune organ index such as thymus and spleen. The 
report believes that the changes of the thymus and 
spleen weight index can reflect the state of immune 
function (Chen et al., 2010). The weight of immune 
organs and thymus (spleen) index can be used as 
indicators of determining immune function. Our research 
showed that baicalein could increase the mice thymus 
and spleen index significantly compared with CTX, and 
indicated that baicalein could enhance the immune 
function of tumor-bearing mice.Bcl-2 is the major gene of 
inhibiting apoptosis which has the effects of inhibiting 
apoptosis and increasing cells lifetime. Meanwhile, Bax is 
a new gene which can promote apoptosis, and it can not 
only antagonize the effect of inhibiting apoptosis from Bcl-
2, but also promote apoptosis directly. Bax is distributed 
in cytoplasm mainly, while Bcl-2 was distributed in 
cytoplasmic and mitochondrial membrane, and they can 
induce apoptosis of tumor cells through the mitochondrial 
pathway. Generally, Bax/Bcl-2 ratio is considered to be a 
key factor of affecting apoptosis, the heterodimer of Bcl-2 
and Bax is increased when Bcl-2 in cells is increasing, 
and then the apoptosis trends were getting weaken. 
However,    when   Bax    is   increased,   the  homodimer  




formatted by Bax would charge, and the cells would go to 
apoptosis easily. So Bax/Bcl-2 ratio was important in 
determining whether cells would go into the state of 
apoptosis (Miao et al., 2005).Our results of immune-
histochemical method showed that the Bax expression of 
tumor tissues in the high dose baicalein group 
increased,and the Bcl-2 expression decreased, while the 
ratio of Bax/Bcl-2 increased to 0.61 compared with the 
control group. All of these results indicated that baicalein 
might induce the apoptosis of U14 cervical cancer cells 
by way of adjusting the expression of Bcl-2 and Bax, 





According to our experiment, we inferred that baicalein 
could inhibit the growth of U14 cervical cancer in vivo and 
it almost had no toxic effects on liver and kidney in mice 
models. Baicalein might induce the apoptosis of tumor 
tissues through the mitochondria (intrinsic) pathway 
which downregulated the level of anti-apoptotic protein 
Bcl-2 and unregulated the level of pro-apoptotic protein 
Bax. Therefore, we propound that this might be one of the 
effective mechanisms on tumor. However, the detailed 
mechanism of inhibiting cervical cancer cells by baicalein 
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